Griselimycin, CAS 26034-16-2

Product Description: Griselimycin is a compound with antituberculosis activity that exhibits good in vitro and in vivo activity against sensitive and resistant Mycobacterium tuberculosis, and its cyclohexyl derivative has high transformative potential.

Applications: COVID-19-immunoregulation

Formula: C57H96N10O12

References: [1]New Griselimycins for Treatment of Tuberculosis

CAS Number: 26034-16-2

Molecular Weight: 1113.43

Research Area: Others

Target: Bacterial

• Artikelnummer: MEXHY-125576-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-125576-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK